Fundz

Onco Xome reported raising $171,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATEFeb 13, 2023$170.5K of $1M raised

Amount Raised

$171,000

$171,000 sold, per SEC Form D (first sale Dec 2, 2022)

Round Type

Pre-Seed

North HollywoodBiotechnology

Quick answer

OncoXome raised $171,000 in a Pre-Seed round, dated December 2, 2022. OncoXome is based in North Hollywood, California, United States.

How much did OncoXome raise?
OncoXome raised $171,000 in a Pre-Seed round on December 2, 2022.
What does OncoXome do?
Manipulating cancer's communication system using exosomes to prevent cancer resistance and induce rapid cancer cell death
Where is OncoXome based and how big is it?
OncoXome is based in North Hollywood, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as OncoXome that raised within 45 days of this round, from Fundz verified event records.

  • Thomas J. Paul raised an undisclosed amount (Funding Round) on January 16, 2023.
  • Sigrid Therapeutics raised $1M (Seed) on January 16, 2023.
  • Kazia Therapeutics raised an undisclosed amount (Funding Round) on January 16, 2023.
  • Morphoceuticals raised $9.8M on January 13, 2023.
  • DeepLook Medical raised $1.5M (Seed) on January 13, 2023.
  • MetaCene raised an undisclosed amount (Seed) on January 12, 2023.

Who to call at OncoXome, and when

A new round usually means OncoXome is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OncoXome raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OncoXome, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OncoXome. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OncoXome

Location

10824 BLOOMFIELD STREET

North Hollywood, California, United States

About

Manipulating cancer's communication system using exosomes to prevent cancer resistance and induce rapid cancer cell death

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OncoXome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for OncoXome's next move

See what Strategic adds

OncoXome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.